Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 255 participants.
Also called NCT01932203
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 255 participants
- Registry
-
NCT01932203
-
- Other papers using this trial's data
- Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01932203. Randomized; quadruple masking; primary purpose treatment. Start 2013-07-17 (actual); primary completion 2019-08-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
- Acronym
- Challenge
- Condition
- Cerebral Small Vessel Disease
- Intervention (Drug)
- aspirin
- Intervention (Drug)
- cilostazol
- Lead sponsor
- Inha University Hospital
- Collaborator
- Otsuka Pharmaceutical Development & Commercialization, Inc.
Record details
- Record id
cardio:ct-nct01932203- Content hash
076ac43d0daa97a94d73db423cb2a6b4cc6930e9cca442fe25093d5da5d20f17